603 related articles for article (PubMed ID: 10716435)
21. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
22. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress.
Offer H; Zurer I; Banfalvi G; Reha'k M; Falcovitz A; Milyavsky M; Goldfinger N; Rotter V
Cancer Res; 2001 Jan; 61(1):88-96. PubMed ID: 11196204
[TBL] [Abstract][Full Text] [Related]
23. Structurally dependent redox property of ribonucleotide reductase subunit p53R2.
Xue L; Zhou B; Liu X; Wang T; Shih J; Qi C; Heung Y; Yen Y
Cancer Res; 2006 Feb; 66(4):1900-5. PubMed ID: 16488986
[TBL] [Abstract][Full Text] [Related]
24. A ribonucleotide reductase gene is a transcriptional target of p53 and p73.
Nakano K; Bálint E; Ashcroft M; Vousden KH
Oncogene; 2000 Aug; 19(37):4283-9. PubMed ID: 10980602
[TBL] [Abstract][Full Text] [Related]
25. Genotoxicity test system based on p53R2 gene expression in human cells: examination with 80 chemicals.
Ohno K; Tanaka-Azuma Y; Yoneda Y; Yamada T
Mutat Res; 2005 Dec; 588(1):47-57. PubMed ID: 16236544
[TBL] [Abstract][Full Text] [Related]
26. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
27. p53 sends nucleotides to repair DNA.
Lozano G; Elledge SJ
Nature; 2000 Mar; 404(6773):24-5. PubMed ID: 10716425
[No Abstract] [Full Text] [Related]
28. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.
Bourdon A; Minai L; Serre V; Jais JP; Sarzi E; Aubert S; Chrétien D; de Lonlay P; Paquis-Flucklinger V; Arakawa H; Nakamura Y; Munnich A; Rötig A
Nat Genet; 2007 Jun; 39(6):776-80. PubMed ID: 17486094
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.
Smith ML; Chen IT; Zhan Q; O'Connor PM; Fornace AJ
Oncogene; 1995 Mar; 10(6):1053-9. PubMed ID: 7700629
[TBL] [Abstract][Full Text] [Related]
30. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
31. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
[TBL] [Abstract][Full Text] [Related]
32. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
[TBL] [Abstract][Full Text] [Related]
33. Circular dichroism and magnetic circular dichroism studies of the active site of p53R2 from human and mouse: iron binding and nature of the biferrous site relative to other ribonucleotide reductases.
Wei PP; Tomter AB; Røhr AK; Andersson KK; Solomon EI
Biochemistry; 2006 Nov; 45(47):14043-51. PubMed ID: 17115699
[TBL] [Abstract][Full Text] [Related]
34. Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools.
Kimura T; Takeda S; Sagiya Y; Gotoh M; Nakamura Y; Arakawa H
Nat Genet; 2003 Aug; 34(4):440-5. PubMed ID: 12858174
[TBL] [Abstract][Full Text] [Related]
35. hRAD17, a structural homolog of the Schizosaccharomyces pombe RAD17 cell cycle checkpoint gene, stimulates p53 accumulation.
Li L; Peterson CA; Kanter-Smoler G; Wei YF; Ramagli LS; Sunnerhagen P; Siciliano MJ; Legerski RJ
Oncogene; 1999 Mar; 18(9):1689-99. PubMed ID: 10208430
[TBL] [Abstract][Full Text] [Related]
36. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia.
Denko NC; Green SL; Edwards D; Giaccia AJ
Exp Cell Res; 2000 Jul; 258(1):82-91. PubMed ID: 10912790
[TBL] [Abstract][Full Text] [Related]
37. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
38. Ablation of p21waf1cip1 expression enhances the capacity of p53-deficient human tumor cells to repair UVB-induced DNA damage.
Therrien JP; Loignon M; Drouin R; Drobetsky EA
Cancer Res; 2001 May; 61(9):3781-6. PubMed ID: 11325852
[TBL] [Abstract][Full Text] [Related]
39. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
[TBL] [Abstract][Full Text] [Related]
40. DNA damage and cell cycle regulation of ribonucleotide reductase.
Elledge SJ; Zhou Z; Allen JB; Navas TA
Bioessays; 1993 May; 15(5):333-9. PubMed ID: 8343143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
